Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19.

O. Yakovenko (Lutsk, Ukraine), T. Yakovenko (Lutsk, Ukraine), O. Liuta (Lutsk, Ukraine)

Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends

Session: Interstitial lung disease, COVID-19 and friends
Session type: E-poster
Number: 2536

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Yakovenko (Lutsk, Ukraine), T. Yakovenko (Lutsk, Ukraine), O. Liuta (Lutsk, Ukraine). Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19.. 2536

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015
Spectrum of interstitial lung diseases (ILDs) and associated prevalence of pulmonary hypertension Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021
Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features Source: Eur Respir J 2006; 27: 143-150 Year: 2006
The burden of pulmonary hypertension Source: Annual Congress 2006 - The burden of pulmonary hypertension Year: 2006
Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016
Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020 Year: 2021
Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia Source: Eur Respir J, 52 (1) 1800545; 10.1183/13993003.00545-2018 Year: 2018
Prevalence and low diagnostics of chronic non-specific pulmonary diseases among pulmonary TB patients Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector Year: 2007
Morphologic evaluation of lung in a scleroderma-like rabbit model Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease Year: 2006
Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 40: 93-100 Year: 2012
Chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension are the conditions predisposing to non-tuberculous mycobacterial lung disease (NTMLD) Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011
The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018 Year: 2018
Interstital lung diseases: update 2005 Source: Annual Congress 2005 - Clinical year in review Year: 2005
Clinical characteristics of postoperative pulmonary infection in lung cancer patients with obstructive pulmonary disease: the trend of microorganisms in bronchial colonization Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006
Bosentan treatment in pulmonary arterial hypertension (PAH) associated with interstitial lung diseases (ILDs) Source: Eur Respir J 2006; 28: Suppl. 50, 426s Year: 2006
Clinical manifestations and prediction rules in patients with pulmonary embolism and prior respiratory disease Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011
Other investigations for differentiating respiratory from cardiac causes of respiratory symptoms Source: Annual Congress 2007 - Primary care: diagnosing and labelling respiratory patients Year: 2007
Interstitial lung diseases in childhood Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=213 Year: 2002
Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013
Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013